Scott Lancaster

1000 total citations
20 papers, 655 citations indexed

About

Scott Lancaster is a scholar working on Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Scott Lancaster has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Psychiatry and Mental health and 3 papers in Surgery. Recurrent topics in Scott Lancaster's work include Cardiac electrophysiology and arrhythmias (8 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Arrhythmias and Treatments (7 papers). Scott Lancaster is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Arrhythmias and Treatments (7 papers). Scott Lancaster collaborates with scholars based in United States, Canada and Belgium. Scott Lancaster's co-authors include Alfred P. Hallstrom, Ellen Graham Renfroe, Sergio L. Pinski, Karen J. Beckman, Dean Follmann, Michael R. Gold, James Coromilas, Andrew E. Epstein, Derek V. Exner and D. George Wyse and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Scott Lancaster

18 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Lancaster United States 10 511 48 36 30 30 20 655
Jessica Ford United States 9 406 0.8× 10 0.2× 21 0.6× 7 0.2× 8 0.3× 18 502
Donald M. Clark United States 7 120 0.2× 34 0.7× 51 1.4× 35 1.2× 10 0.3× 21 342
Maurício Pimentel Brazil 11 185 0.4× 25 0.5× 36 1.0× 47 1.6× 24 0.8× 37 390
Ying Bai China 14 466 0.9× 46 1.0× 17 0.5× 20 0.7× 39 1.3× 34 657
David Trueman United States 12 85 0.2× 52 1.1× 52 1.4× 15 0.5× 91 3.0× 48 366
Diane V Thompson United States 14 361 0.7× 29 0.6× 111 3.1× 32 1.1× 3 0.1× 27 540
Henrik Almroth Sweden 11 203 0.4× 67 1.4× 40 1.1× 10 0.3× 20 0.7× 19 342
H J Bethell United Kingdom 11 329 0.6× 5 0.1× 29 0.8× 28 0.9× 11 0.4× 29 449
Raymond Harris United States 12 148 0.3× 14 0.3× 54 1.5× 10 0.3× 18 0.6× 45 342

Countries citing papers authored by Scott Lancaster

Since Specialization
Citations

This map shows the geographic impact of Scott Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Lancaster more than expected).

Fields of papers citing papers by Scott Lancaster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Lancaster. The network helps show where Scott Lancaster may publish in the future.

Co-authorship network of co-authors of Scott Lancaster

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Lancaster. A scholar is included among the top collaborators of Scott Lancaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Lancaster. Scott Lancaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alphs, Larry, et al.. (2025). Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale. Psychopharmacology Bulletin. 40(2). 41–53.
2.
Lancaster, Scott, et al.. (2020). Appendicitis in Neutropenic Pediatric Oncology Patients: A Case Series and Review of the Literature. Journal of Pediatric Hematology/Oncology. 42(8). e835–e838.
3.
Velligan, Dawn I., Larry Alphs, Scott Lancaster, Robert Morlock, & Jim Mintz. (2009). Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia. Psychiatry Research. 169(2). 97–100. 49 indexed citations
4.
Carneiro, Benedito A., Nathan Bahary, Barry C. Lembersky, et al.. (2009). Phase II study of biweekly cetuximab (C) and irinotecan (I) as a second-line regimen for metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 27(15_suppl). e15088–e15088. 1 indexed citations
5.
Ramanathan, Ramesh K., Marwan Fakih, Smitha Krishnamurthi, et al.. (2008). Phase II study of irinotecan (I) and cetuximab (C) on an every 2 week schedule, as second line therapy in patients (pts) with advanced colo-rectal cancer (CRC). Journal of Clinical Oncology. 26(15_suppl). 15050–15050. 1 indexed citations
6.
McIntyre, Roger S., John Panagides, Larry Alphs, et al.. (2007). P.2.e.012 Treatment of mania in bipolar I disorder: a placebo- and olanzapine-controlled trial of asenapine (ARES 7501005). European Neuropsychopharmacology. 17. S383–S383. 5 indexed citations
7.
Leeuwenkamp, Oscar, et al.. (2006). PMH4 ASSOCIATION BETWEEN CHANGES ON THE NEGATIVE SYMPTOM ASSESSMENT SCALE AND MEASUREES OF FUNCTIONAL OUTCOME IN SCHIZOPHRENIA. Value in Health. 9(6). A310–A310. 2 indexed citations
8.
9.
Raitt, Merritt H., Ellen Graham Renfroe, Andrew E. Epstein, et al.. (2001). “Stable” Ventricular Tachycardia Is Not a Benign Rhythm. Circulation. 103(2). 244–252. 53 indexed citations
10.
Exner, Derek V., Sergio L. Pinski, D. George Wyse, et al.. (2001). Electrical Storm Presages Nonsudden Death. Circulation. 103(16). 2066–2071. 268 indexed citations
11.
Pinski, Sergio L., Qing Yao, Andrew E. Epstein, et al.. (2000). Determinants of outcome in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry. American Heart Journal. 139(5). 804–813. 23 indexed citations
12.
13.
Epstein, Andrew E., Judy Powell, Qing Yao, et al.. (1999). In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival. Journal of the American College of Cardiology. 34(4). 1111–1116. 18 indexed citations
14.
Domanski, Michaël, Andrew E. Epstein, Alfred P. Hallstrom, et al.. (1999). Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. Journal of the American College of Cardiology. 34(4). 1090–1095. 130 indexed citations
15.
Epstein, Andrew E., Ellen Graham Renfroe, D.S. Cannom, et al.. (1998). In-hospital vs Out-of-hospital presentation of life-threatening ventricular arrhythmia predicts survival - results from the Antiarrhythmics vs Implantable Defibrillators (AVID) registry. Journal of the American College of Cardiology. 31. 435–435. 1 indexed citations
16.
Gorkin, Larry, Eleanor Schron, Steven A. Shea, et al.. (1996). Clinical trial enrollers vs. nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Controlled Clinical Trials. 17(1). 46–59. 52 indexed citations
17.
18.
Manni, Andrea, et al.. (1991). Kinetic and morphometric responses of heterogeneous populations of NMU-induced rat mammary tumor cells to hormone and antipolyamine therapyin vivo. Breast Cancer Research and Treatment. 17(3). 179–186. 3 indexed citations
19.
English, Hugh F., Daniel F. Heitjan, Scott Lancaster, & R J Santen. (1991). Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer.. PubMed. 51(7). 1760–5. 9 indexed citations
20.
Lancaster, Scott, Hugh F. English, Laurence M. Demers, & Andrea Manni. (1988). Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cells in vivo.. PubMed. 48(11). 3276–81. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica Ford Breakdown of academic impact, for papers by Donald M. Clark Breakdown of academic impact, for papers by Maurício Pimentel Breakdown of academic impact, for papers by Ying Bai Breakdown of academic impact, for papers by David Trueman Breakdown of academic impact, for papers by Diane V Thompson Breakdown of academic impact, for papers by Henrik Almroth Breakdown of academic impact, for papers by H J Bethell Breakdown of academic impact, for papers by Raymond Harris
Rankless by CCL
2026